We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Comes Down on Contamination Risks at Genentech Avastin Plant
FDA Comes Down on Contamination Risks at Genentech Avastin Plant
June 4, 2012
Genentech may need to tune up manufacturing practices at a San Francisco, Calif., plant that makes cancer drug Avastin.